Form 4 Filing for Arcturus Therapeutics Holdings Inc.

This Form 4 filing details a derivative transaction by BARLOW JAMES F, a director at Arcturus Therapeutics Holdings Inc. On June 5, 2026, 15,000 stock options were granted with an exercise price of $7.30. These options, which represent the right to buy Common Stock, vest monthly over one year. The transaction code is "A" for acquisition, and the post-transaction shares owned are 15000. The filing is made on June 15, 2026, based on transactions on June 5, 2026. This is part of the 2026 annual grant to the Reporting Person as a member of the Board of Directors.